Brief: SOPHiA Genetics Reports Fourth Quarter and Full Year 2024 Results
04/03/2025 12:07
March 4 (Reuters) - Sophia Genetics SA 90B.F: SOPHIA GENETICS SA - 2025 REVENUE GUIDANCE $72 MILLION TO $76 MILLION SOPHIA GENETICS SA - Q4 REVENUE $17.7 MILLION, UP 4% YEAR-OVER-YEAR SOPHIA GENETICS SA: EXPECTS TO BE APPROACHING ADJUSTED EBITDA BREAKEVEN BY END OF 2026 & CROSSING OVER TO POSITIVE ADJUSTED EBITDA IN H2 OF 2027 SOPHIA GENETICS SA: QTRLY NET LOSS 0.23 PER SHARE Source text: ID:nPn1hJ1Kza Further company coverage: 90B.F ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sophia Genetics SA
See all newsSwitzerland's SOPHiA GENETICS Q2 revenue rises on Liquid Biopsy growth
Brief: Sophia Genetics Enters Collaboration To Develop Companion Diagnostics For Precision Oncology Therapies
Sophia Genetics dips on $50 mln stock sale
Brief: Sophia Genetics Announces Pricing Of $50 Million Public Offering Of Ordinary Shares
Brief: Sophia Genetics Announces Proposed Public Offering Of Ordinary Shares